DuPont’s new flagship dairy enzyme, DuPont™ Danisco® Nurica™, offers a new dietary solution for the roughly 65% of the global population who are affected by lactose intolerance. Conventionally, many people with lactose intolerance use lactase-based products to break down the lactose, or milk sugar, that they consume into component parts that are easier for the body to absorb.
Nurica™ enables the galactose molecule to be naturally transformed into a prebiotic dietary fiber called GOS – galactooligosaccharides – facilitating up to 35% total sugar reduction. Research shows that GOS stimulates beneficial gut bacteria and contributes to increased mineral absorption and a sense of satiety, or fullness. Nurica™ can be stabilized in a variety of fermented dairy products, such as yogurt, sour cream, and more. This will allow more people to enjoy common food staples without negative health impacts.
The 50 top leaders at DuPont Nutrition & Biosciences have identified seven central goals and two focus areas within the UN’s Sustainable Development Goals (SDGs). In autumn, the company will host a workshop presenting tools for others with the same ambitions.
Expectant mothers can wake up to a wellness report of their unborn child and be notified if fetal heartbeat and movement are within acceptable ranges with the new Owlet Band, winner of two CES awards in the categories of Wearable Technology and Tech to Change the World. Specialized sensors housed in a fabric band that sits around the mother's abdomen track fetal heart rate and kick count, sending real-time data to a smartphone.
The agreement, supported by an initial investment of more than one million euros mainly made by DuPont, exemplifies the concept of circular economy and will lead to significant reductions in energy, water and transport consumption for both companies.